181 related articles for article (PubMed ID: 24130202)
1. Application of methods for central statistical monitoring in clinical trials.
Kirkwood AA; Cox T; Hackshaw A
Clin Trials; 2013 Oct; 10(5):783-806. PubMed ID: 24130202
[TBL] [Abstract][Full Text] [Related]
2. Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.
Lindblad AS; Manukyan Z; Purohit-Sheth T; Gensler G; Okwesili P; Meeker-O'Connell A; Ball L; Marler JR
Clin Trials; 2014 Apr; 11(2):205-17. PubMed ID: 24296321
[TBL] [Abstract][Full Text] [Related]
3. Central statistical monitoring: detecting fraud in clinical trials.
Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
[TBL] [Abstract][Full Text] [Related]
4. A statistical approach to central monitoring of data quality in clinical trials.
Venet D; Doffagne E; Burzykowski T; Beckers F; Tellier Y; Genevois-Marlin E; Becker U; Bee V; Wilson V; Legrand C; Buyse M
Clin Trials; 2012 Dec; 9(6):705-13. PubMed ID: 22684241
[TBL] [Abstract][Full Text] [Related]
5. An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.
Mascha EJ; Vetter TR; Pittet JF
Anesth Analg; 2017 Oct; 125(4):1381-1385. PubMed ID: 28786843
[TBL] [Abstract][Full Text] [Related]
6. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
7. Avoid lost discoveries, because of violations of standard assumptions, by using modern robust statistical methods.
Wilcox R; Carlson M; Azen S; Clark F
J Clin Epidemiol; 2013 Mar; 66(3):319-29. PubMed ID: 23195918
[TBL] [Abstract][Full Text] [Related]
8. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
Paciorek CJ; Liu Y;
Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
[TBL] [Abstract][Full Text] [Related]
9. Are these data real? Statistical methods for the detection of data fabrication in clinical trials.
Al-Marzouki S; Evans S; Marshall T; Roberts I
BMJ; 2005 Jul; 331(7511):267-70. PubMed ID: 16052019
[TBL] [Abstract][Full Text] [Related]
10. Five easy pieces on evidence-based medicine (4).
Kalso E; Edwards J; McQuay HJ; Moore RA
Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
[No Abstract] [Full Text] [Related]
11. Remote preenrollment checking of consent forms to reduce nonconformity.
Journot V; Pérusat-Villetorte S; Bouyssou C; Couffin-Cadiergues S; Tall A; Chêne G;
Clin Trials; 2013; 10(3):449-59. PubMed ID: 23529696
[TBL] [Abstract][Full Text] [Related]
12. A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.
van den Bor RM; Vaessen PWJ; Oosterman BJ; Zuithoff NPA; Grobbee DE; Roes KCB
J Clin Epidemiol; 2017 Jul; 87():59-69. PubMed ID: 28412468
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials: robust tests are wonderful for imperfect data.
Cleophas TJ
Am J Ther; 2015; 22(1):e1-5. PubMed ID: 23896742
[TBL] [Abstract][Full Text] [Related]
14. Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience.
Hanna M; Minga A; Fao P; Borand L; Diouf A; Mben JM; Gad RR; Anglaret X; Bazin B; Chene G;
Clin Trials; 2013 Apr; 10(2):300-18. PubMed ID: 23345311
[TBL] [Abstract][Full Text] [Related]
15. Integrity of scientific data: transparency of clinical trial data.
Moore N; Juillet Y; Bertoye PH;
Therapie; 2007; 62(3):203-9, 211-6. PubMed ID: 17803887
[TBL] [Abstract][Full Text] [Related]
16. Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.
Edwards P; Shakur H; Barnetson L; Prieto D; Evans S; Roberts I
Clin Trials; 2014 Jun; 11(3):336-343. PubMed ID: 24346610
[TBL] [Abstract][Full Text] [Related]
17. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
18. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
[TBL] [Abstract][Full Text] [Related]
19. The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.
Olsen R; Bihlet AR; Kalakou F; Andersen JR
Eur J Clin Pharmacol; 2016 Apr; 72(4):399-412. PubMed ID: 26729259
[TBL] [Abstract][Full Text] [Related]
20. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.
Buyse M; George SL; Evans S; Geller NL; Ranstam J; Scherrer B; Lesaffre E; Murray G; Edler L; Hutton J; Colton T; Lachenbruch P; Verma BL
Stat Med; 1999 Dec; 18(24):3435-51. PubMed ID: 10611617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
